ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ELTX Elicio Therapeutics Inc

7.75
-0.15 (-1.90%)
15 Mar 2025 - Closed
Delayed by 15 minutes

Elicio Therapeutics Financial Summary

The current ELTX market cap is 83.63M. The company's latest EPS is USD -3.2614 and P/E is -2.39.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -10.56M-9.39M-10.24M-10.92M-10.35M
Net Income -10.66M-8.95M-11.83M-7.23M-18.84M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.49M2.88M28.31M2.3M0
Operating Income -38.59M-55.34M-39.31M-39.62M-35.75M
Net Income -40.66M-80.11M-54.57M-38.81M-35.2M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 30.99M27.15M24.48M15.75M38.39M
Total Liabilities 17.7M15.77M19.61M17.4M57.37M
Total Equity 13.29M11.37M4.87M-1.65M-18.99M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 11.89M47.35M96.51M52.79M27.15M
Total Liabilities 30.47M137.8M15.01M9.02M15.77M
Total Equity -18.59M-90.45M81.51M43.77M11.37M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -22.8M-32.69M-12.12M-21.05M-28.32M
Investing -32k-32k3k-39k-39k
Financing 31.61M38.61M11.02M11.34M42.09M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -24.59M-22.89M-52.64M-38.39M-32.69M
Investing -242k-41k-382k N/A -32k
Financing 4.89M52.41M107.17M-60k38.61M
Market Cap 83.63M
Price to Earnings Ratio -2.39
Price to Sales Ratio 0
Price to Cash Ratio 6.52
Price to Book Ratio 7.39
Dividend Yield -

Share Statistics

Shares Outstanding 10.79M
Average Volume (1 week) 29.21k
Average Volume (1 Month) 35.74k
52 Week Change 51.96%
52 Week High 11.45
52 Week Low 3.3419
Spread (Intraday) 7.49 (83.31%)

Company Info

Company Name Elicio Therapeutics Inc
Address corporation trust center
wilmington, delaware 19801
Website https://www.elicio.com
Industry pharmaceutical preparations (2834)